An international online platform settled with the Connecticut attorney general's office Wednesday and agreed to stop selling GLP-1 weight-loss medications to customers in the United States, according to a press release from the attorney general's office.The platform, called Made-in-China, had sold so-called "research grade" GLP-1 drugs without prescriptions or any medical oversight, which are not …

Click here for the full article!